Beryl Drugs Limited
BSE: BERLDRG.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Sanjay Sethi
- Employees
- 22
- Headquarters
- Indore, India
- IPO year
- 2005
- Market cap
- ₹104.4M
- Website
- http://www.beryldrugs.com
Loading BERLDRG…
Loading profile data…Frequently asked questions about BERLDRG
What does Beryl Drugs Limited (BERLDRG.BO) do?
Beryl Drugs Ltd. engages in the manufacture of bulk drugs. It offers small volume injectables in liquid and dry form, eye and ear drops, Intravenous fluids in polypack and glass bottles and veterinary medicines. The company was founded on August 24, 1993 and is headquartered in Indore, India.
Where does BERLDRG.BO trade?
Beryl Drugs Limited (BERLDRG.BO) trades on the Bombay Stock Exchange.
What sector is BERLDRG.BO in?
Beryl Drugs Limited (BERLDRG.BO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Beryl Drugs Limited?
Sanjay Sethi is the chief executive officer of Beryl Drugs Limited (BERLDRG.BO).
Where is Beryl Drugs Limited headquartered?
Beryl Drugs Limited is headquartered in India.
Does BERLDRG.BO pay a dividend?
Beryl Drugs Limited (BERLDRG.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BERLDRG.BO go public?
Beryl Drugs Limited (BERLDRG.BO) completed its initial public offering in 2005.